In most cancers, TGM3 expression levels were positively correlated with most m1A-, m5C- and m6A-modified genes, especially in high-risk Wilms tumor (WT), GBM, OV, KIRP, KIPAN, ACC, READ, SARC, BRCA, LGG, GBMLGG, THCA and KIRC (Figure 7E). This evidence concerns the gene TGM3 and glioblastoma.